Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes (vol 2022, 9322332, 2022)

被引：0
|
作者：
Fu, Yuanyuan [1 ]
Hu, Ling [2 ]
Ren, Hong-Wei [2 ]
Zuo, Yi [1 ,2 ]
Chen, Shaoqiu [1 ]
Zhang, Qiu-Shi [2 ]
Shao, Chen [2 ]
Ma, Yao [2 ]
Wu, Lin [2 ]
Hao, Jun-Jie [2 ]
Wang, Chuan-Zhen [2 ]
Wang, Zhanwei [3 ]
Yanagihara, Richard [4 ]
Deng, Youping [1 ]
机构：
[1] Univ Hawaii, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI 96822 USA
[2] Wuhan Univ Sci & Technol, Tianyou Hosp, Wuhan, Hubei, Peoples R China
[3] Univ Hawaii, Univ Hawaii Canc Ctr, Canc Epidemiol Program, Honolulu, HI USA
[4] Univ Hawaii, John Burns Sch Med, Dept Pediat, Honolulu, HI USA
来源：
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY | 2022年 / 2022卷
关键词：
D O I：
10.1155/2022/9838923
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The impact of COVID-19 on Diabetic Ketoacidosis patients (vol 16, 102389, 2022)
    Khan, Faraz
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (05)
  • [22] Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
    Scheen, A. J.
    Marre, M.
    Thivolet, C.
    DIABETES & METABOLISM, 2020, 46 (04) : 265 - 271
  • [23] The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19
    Kuluozturk, Mutlu
    Deveci, Figen
    Turgut, Teyfik
    oner, Onsel
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (08) : 1061 - 1068
  • [24] Prognostic factors for COVID-19 patients
    Onal, Ugur
    Guclu, Ozge Aydin
    Akalin, Halis
    Ozturk, Nilufer Aylin Acet
    Semet, Cihan
    Demirdogen, Ezgi
    Dilektasli, Asli Gorek
    Saglik, Imran
    Kazak, Esra
    Ozkaya, Guven
    Coskun, Funda
    Ediger, Dane
    Heper, Yasemin
    Ursavas, Ahmet
    Yilmaz, Emel
    Uzaslan, Esra
    Karadag, Mehmet
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (03): : 409 - 417
  • [25] Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes
    Zhou, Xiaoying
    Lu, Huixia
    Sang, Miaomiao
    Qiu, Shanhu
    Yuan, Yang
    Wu, Tongzhi
    Chen, Junhao
    Sun, Zilin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [26] The Prognostic Utility of Cytokines in Hospitalized COVID-19 Patients
    Andrejkovits, Akos Vince
    Hutanu, Adina
    Susanyi, Ervin Jozsef
    Negrea, Valentina
    Vasiesiu, Anca Meda
    JOURNAL OF CRITICAL CARE MEDICINE, 2023, 9 (04): : 208 - 217
  • [27] Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients
    Khamidullina, Zemfira
    Avzaletdinova, Diana
    Gareeva, Diana
    Morugova, Tatyana
    Lakman, Irina
    Kopp, Kristen
    Fiedler, Lukas
    Motloch, Lukas J.
    Zagidullin, Naufal
    BIOMEDICINES, 2024, 12 (02)
  • [28] Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans (vol 22, 552, 2022)
    Ashktorab, Hassan
    Pizuorno, Antonio
    Adeleye, Folake
    Laiyemo, Adeyinka
    Dalivand, Maryam Mehdipour
    Aduli, Farshad
    Sherif, Zaki A.
    Oskrochi, Gholamreza
    Angesom, Kibreab
    Oppong-Twene, Philip
    Challa, Suryanarayana Reddy
    Okorie, Nnaemeka
    Moon, Esther S.
    Romos, Edward
    Jones-Wonni, Boubini
    Kone, Abdoul Madjid
    Rankine, Sheldon
    Thrift, Camelita
    Scholes, Derek
    Ekwunazu, Chiamaka
    Banson, Abigail
    Mitchell, Brianna
    Maskalo, Guttu
    Ross, Jillian
    Curtis, Julencia
    Kim, Rachel
    Gilliard, Chandler
    Ahuja, Geeta
    Mathew, Joseph
    Gavin, Warren
    Kara, Areeba
    Hache-Marliere, Manuel
    Palaiodimos, Leonidas
    Mani, Vishnu R.
    Kalabin, Aleksandr
    Gayam, Vijay Reddy
    Garlapati, Pavani Reddy
    Miller, Joseph
    Chirumamilla, Lakshmi Gayathri
    Jackson, Fatimah
    Carethers, John M.
    Kamangar, Farin
    Brim, Hassan
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [29] Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial (vol 12, 453, 2022)
    Coppock, Dagan
    Violet, Pierre-Christian
    Vasquez, Gustavo
    Belden, Katherine
    Foster, Michael
    Mullin, Bret
    Magee, Devon
    Mikell, Isabelle
    Shah, Lokesh
    Powers, Victoria
    Curcio, Brian
    Monti, Daniel
    Levine, Mark
    LIFE-BASEL, 2022, 12 (09):
  • [30] Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study (vol 83, 104208, 2022)
    Ozonoff, Al
    Schaenman, Joanna
    Jayavelu, Naresh Doni
    Milliren, Carly E.
    Calfee, Carolyn S.
    Cairns, Charles B.
    Kraft, Monica
    Baden, Lindsey R.
    Shaw, Albert C.
    Krammer, Florian
    van Bakel, Harm
    Esserman, Denise A.
    Liu, Shanshan
    Sesma, Ana Fernandez
    Simon, Viviana
    Hafler, David A.
    Montgomery, Ruth R.
    Kleinstein, Steven H.
    Levy, Ofer
    Bime, Chris
    Haddad, Elias K.
    Erle, David J.
    Pulendran, Bali
    Nadeau, Kari C.
    Davis, Mark M.
    Hough, Catherine L.
    Messer, William B.
    Higuita, Nelson I. Agudelo
    Metcalf, Jordan P.
    Atkinson, Mark A.
    Brakenridge, Scott C.
    Corry, David
    Kheradmand, Farrah
    Ehrlich, Lauren I. R.
    Melamed, Esther
    Mccomsey, Grace A.
    Sekaly, Rafick
    Diray-Arce, Joann
    Peters, Bjoern
    Augustine, Alison D.
    Reed, Elaine F.
    Altman, Matthew C.
    Becker, Patrice M.
    Rouphael, Nadine
    EBIOMEDICINE, 2023, 98
12345